EQNR323.30-4.60%
MOWI187.80-1.57%
YARA432.10+0.30%
TEL144.40+1.69%
Brent$73.75-2.61%
USD/NOK9,8084−0,34 %
EUR/NOK11,2140−0,18 %
LIVE · 14:40 UTC
5619$870.0057

5619.T

SoftwareLatest Reported

The company maintains a strong liquidity position, with cash and equivalents amounting to ¥1,675,916,000. Its liquidity ratio, as reflected in the current ratio of 11.51, indicates a robust ability to meet short-term obligations. The company has no long-term debt, and its debt-to-equity ratio is 0.0, suggesting a conservative capital structure with no leverage. Profitability metrics reveal a challenging financial position. The company reported a net loss of ¥23,005,000 and an operating loss of ¥33,937,000. Return on equity (ROE) and return on assets (ROA) are negative at -1.18% and -1.09%, respectively, indicating poor returns relative to equity and total assets. These figures fall below the typical performance of the software industry, where positive returns are expected for sustainable operations. The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic breakdown provided. This lack of diversification may expose the company to higher operational and market risks, particularly in the health care technology sector, which is subject to regulatory and technological changes. Looking ahead, the company's growth trajectory is uncertain. With a negative operating cash flow of ¥25,348,000 and a free cash flow of ¥19,108,000, the company is not generating sufficient cash to support operations or growth initiatives. The absence of revenue growth data and the lack of disclosed future revenue projections make it difficult to assess the company's potential for expansion or market capture. Risk factors include the company's current financial losses and the absence of long-term debt, which may limit its ability to finance growth or respond to market opportunities. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. However, the company's negative cash flows and operating losses suggest potential future liquidity constraints if the financial performance does not improve. Recent events, as reflected in the latest financial filing, show the company is operating at a loss with no disclosed material events or strategic initiatives that could alter its financial trajectory. The absence of recent significant developments or strategic announcements may indicate a lack of momentum or innovation in the company's operations.

30-day price · 5619-15.00 (-1.7%)
Low$839.00High$884.00Close$847.00As of15 May, 00:00 UTC
Profile
Company5619.T
Ticker5619.T
SectorTechnology
BusinessSoftware & IT Services
Industry groupSoftware & IT Services
IndustrySoftware
AI analysis

Business. The company operates in the software industry, providing software solutions primarily within the health care technology sector.

Classification. The company is classified under the Technology economic sector, Software & IT Services business sector, and Software industry with a confidence level of 0.92.

The company maintains a strong liquidity position, with cash and equivalents amounting to ¥1,675,916,000. Its liquidity ratio, as reflected in the current ratio of 11.51, indicates a robust ability to meet short-term obligations. The company has no long-term debt, and its debt-to-equity ratio is 0.0, suggesting a conservative capital structure with no leverage. Profitability metrics reveal a challenging financial position. The company reported a net loss of ¥23,005,000 and an operating loss of ¥33,937,000. Return on equity (ROE) and return on assets (ROA) are negative at -1.18% and -1.09%, respectively, indicating poor returns relative to equity and total assets. These figures fall below the typical performance of the software industry, where positive returns are expected for sustainable operations. The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic breakdown provided. This lack of diversification may expose the company to higher operational and market risks, particularly in the health care technology sector, which is subject to regulatory and technological changes. Looking ahead, the company's growth trajectory is uncertain. With a negative operating cash flow of ¥25,348,000 and a free cash flow of ¥19,108,000, the company is not generating sufficient cash to support operations or growth initiatives. The absence of revenue growth data and the lack of disclosed future revenue projections make it difficult to assess the company's potential for expansion or market capture. Risk factors include the company's current financial losses and the absence of long-term debt, which may limit its ability to finance growth or respond to market opportunities. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. However, the company's negative cash flows and operating losses suggest potential future liquidity constraints if the financial performance does not improve. Recent events, as reflected in the latest financial filing, show the company is operating at a loss with no disclosed material events or strategic initiatives that could alter its financial trajectory. The absence of recent significant developments or strategic announcements may indicate a lack of momentum or innovation in the company's operations.
Key takeaways
  • The company has a strong liquidity position with no long-term debt and a high current ratio.
  • The company is currently unprofitable, with negative returns on equity and assets.
  • Revenue is concentrated in a single segment, with no geographic diversification disclosed.
  • The company is not generating positive cash flows from operations, which may hinder growth.
  • There are no immediate liquidity or dilution risks, but the financial performance is a concern.
Financial snapshot
PeriodLatest reported
CurrencyJPY
Revenue$1.08B
Gross profit$823.7M
Operating income-$33.9M
Net income-$23.0M
R&D
SG&A
D&A
SBC
Operating cash flow-$25.3M
CapEx-$498.0k
Free cash flow-$19.1M
Total assets$2.12B
Total liabilities$167.5M
Total equity$1.95B
Cash & equivalents$1.68B
Long-term debt$0.00
Valuation
Market price$870.00
Market cap$3.05B
Enterprise value$1.38B
P/E
Reported non-GAAP P/E
EV/Revenue1.3
EV/Op income
EV/OCF
P/B1.6
P/Tangible book1.6
Tangible book$1.95B
Net cash$1.68B
Current ratio11.5
Debt/Equity0.0
ROA-1.1%
ROE-1.2%
Cash conversion1.1%
CapEx/Revenue-0.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Software · cohort 779 companies
Metric5619Activity
Op margin-3.1%1.9% medp25 -17.3% · p75 13.3%below median
Net margin-2.1%2.4% medp25 -16.3% · p75 12.7%below median
Gross margin76.4%55.8% medp25 32.4% · p75 76.0%top quartile
R&D / revenue24.3% medp25 12.6% · p75 50.3%
CapEx / revenue-0.1%-3.6% medp25 -9.9% · p75 -0.9%top quartile
Debt / equity0.0%5.4% medp25 0.2% · p75 31.9%bottom quartile
Observations
Competitor context
MSFTMicrosoftUSPeer
Derived from classification anchor Software.
Software, Software & IT Services, Technology
CRMSalesforceUSPeer
Derived from classification anchor Software.
Software, Software & IT Services, Technology
NOWServiceNowUSPeer
Derived from classification anchor Software.
Software, Software & IT Services, Technology
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 08:00 UTC#7649b3d4
Market quoteclose JPY 875.00 · shares 0.00B diluted
no public URL
2026-05-04 08:00 UTC#13a01f3c
Source: analysis-pipeline (hybrid)Generated: 2026-05-26 23:49 UTCJob: 9d510612